A US Appeals Court has issued a temporary halt on the mail delivery of mifepristone, an abortion pill, following a legal challenge. This decision comes after the US Supreme Court, in 2024, rejected an attempt by anti-abortion groups and physicians to impose restrictions on the medication, citing their lack of legal standing to pursue the case. The ruling has significant implications for access to the medication, which is commonly used in medical abortions across the country. Further developments are anticipated as the legal proceedings continue.
Related Articles
Don't miss out on breaking stories and in-depth articles.